TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $878 | -44.8% | 2,509 | -25.9% | 0.00% | – |
| Q2 2023 | $1,590 | -52.4% | 3,384 | -30.5% | 0.00% | – |
| Q1 2023 | $3,337 | -8.2% | 4,872 | +40.7% | 0.00% | – |
| Q4 2022 | $3,636 | -75.8% | 3,462 | -4.0% | 0.00% | – |
| Q3 2022 | $15,000 | -66.7% | 3,607 | -54.5% | 0.00% | – |
| Q2 2022 | $45,000 | +114.3% | 7,924 | +134.2% | 0.00% | – |
| Q1 2022 | $21,000 | -30.0% | 3,384 | -1.2% | 0.00% | – |
| Q4 2021 | $30,000 | +114.3% | 3,424 | +95.7% | 0.00% | – |
| Q3 2021 | $14,000 | -17.6% | 1,750 | 0.0% | 0.00% | – |
| Q2 2021 | $17,000 | -55.3% | 1,750 | -37.9% | 0.00% | – |
| Q1 2021 | $38,000 | +192.3% | 2,816 | +221.8% | 0.00% | – |
| Q4 2020 | $13,000 | +44.4% | 875 | +75.0% | 0.00% | – |
| Q3 2020 | $9,000 | +125.0% | 500 | -33.4% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 751 | -24.9% | 0.00% | – |
| Q1 2020 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,019,848 | $7,873,000 | 15.20% |
| Mesirow Financial Investment Management, Inc. | 40,005 | $309,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 80,000 | $618,000 | 0.59% |
| DRW Securities, LLC | 1,000,000 | $7,720,000 | 0.34% |
| GAGNON SECURITIES LLC | 282,229 | $2,179,000 | 0.32% |
| PRINCETON CAPITAL MANAGEMENT LLC | 128,037 | $988,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 145,295 | $1,122,000 | 0.11% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $170,000 | 0.10% |
| CARLSON CAPITAL L P | 227,701 | $1,758,000 | 0.09% |
| MYDA Advisors LLC | 40,000 | $309,000 | 0.09% |